Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran

  • Minoo Mohraz Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Farhad Mehrkhani Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Sara Jam Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Seyed Ahmad SeyedAlinaghi Mail Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Duman Sabzvari Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Fatemeh Fattahi Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Hossain Jabbari Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahboubeh Hajiabdolbaghi Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
HIV/AIDS, Seroprevalence, Toxoplasma gondii, Toxoplasmosis


Toxoplasma gondii has arisen as an important opportunistic agent especially in the central nervous system and in advanced HIV disease can cause significant morbidity and mortality. This study was carried out to determine the seroprevalence of toxoplasmosis among HIV-positive patients in Iran. Blood samples were collected from 201 HIV-positive patients and anti-toxoplasma antibodies were detected by using conventional ELISA. An antibody titer of >3 IU/ml was considered positive. The majority of studied patients were male (male to female ratio: 5 to 1) with the mean age of 36 ± 1 yrs. The seroprevalence of toxoplasmosis in HIV-positive patients was 49.75%. The mean CD4 count in HIV patients with positive toxoplasma serology was 332.5 ± 22.4 cells/µl. Only 1% of the patients had IgM anti-toxoplasma antibodies and 10% of the patients had clinical toxoplasma encephalitis. The mean CD4 count in this group was 66.4 ± 15.5 cells/µl and there was a significant association between CD4 count and rate of toxoplasma encephalitis (P<0.001). Previous reports suggested that toxoplasma encephalitis could be prevented by appropriate chemoprophylaxis. In view of the relatively high prevalence of toxoplasma infection found among the HIVinfected patients in our study, we suggest that routine screening for toxoplasma should be undertaken for all HIV-infected patients in Iran.


Israelski DM, Remington JS. AIDS-associated toxoplasmosis. In: Sande MA, Volberding PA, eds. The medical management of AIDS, 3rd ed. Philadelphia: WB Saunders, 1992, pp. 319-345.

Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-22.

Grant IH, Gold JW, Rosenblum M, Niedzwiecki D,m Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990; 4: 519-521.

Holliman RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect 1990; 105: 415-18.

Pauwels A, Meyohas MC, Eliaszewicz M, Legendre C, Mougeot G, Frottier J. Toxoplasma colitis in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87: 518-19.

Zufferey J, Sugar A, Rudaz P, Bille J, Glauser MP, Chave JP. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1993; 12: 591-95.

Peterson PK, Gekker G, Hu S, Chao CC. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. J Infect Dis 1993; 168: 1472-78.

Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1643-48.

Repáraz Padrós J, Regalado de los Cobos J, Uriz Ayestarán J. [Brain lesions in patients with acquired immunodeficiency syndrome]. Enferm Infecc Microbiol Clin 1991; 9: 85-9.

Jacquier P, Hohlfeld P, Vorkauf H, Zuber P. [Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence monitored in pregnant women 1990-1991]. Schweiz Med Wochenschr Suppl 1995; 65: 29S-38S.

Assmar M, Amirkhani A, Piazak N, Hovanesian A, Kooloobandi A, Etessami R. [Toxoplasmosis in Iran. Results of a seroepidemiological study]. Bull Soc Pathol Exot 1997; 90: 19-21.

Jones JL, Hanson DL, Chu SY, Ciesielski CA, Kaplan JE, Ward JW, Navin TR. Toxoplasmic encephalitis in HIVinfected persons: risk factors and trends. The adult/adolescent spectrum of disease group. AIDS 1996; 10: 1393-99.

Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, Minkoff H, Piessens E, Kovacs A, Anastos K, Cohen MH. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis 2002; 35: 1414-7.

Candolfi E, Partisani ML, De Mautort E, Bethencourt S,mFrantz M, Kien T, Lang J M. [Seroprevalence of toxoplasmosis in 346 HIV infected patients in the east of France. Serological follow-up study in patients not infected with Toxoplasma gondii]. Presse Med 1992; 21: 394-5.

Galván Ramírez ML, Valdez Alvarado V, Vargas Gutierrez G, Jiménez González O, García Cosio C, VielmamSandoval M. Prevalence of IgG and IgM anti-Toxoplasma antibodies in patients with HIV and acquired immunodeficiency syndrome (AIDS). Rev Soc Bras Med Trop 1997; 30: 465-7.

Raffi F, Aboulker JP, Michelet C, Reliquet V, Pelloux H, Huart A, Poizot-Martin I, Morlat P, Dupas B, Mussini JM, Leport C. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO study group. AIDS 1997; 11: 177-84.

Zumla A, Savva D, Wheeler RB, Hira SK, Luo NP, Kaleebu P, Sempala SK, Johnson JD, Holliman R. Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 1991; 85: 227-9.

Wanachiwanawin D, Sutthent R, Chokephaibulkit K, Mahakittikun V, Ongrotchanakun J, Monkong N. Toxoplasma gondii antibodies in HIV and non-HIV infected Thai pregnant women. Asian Pac J Allergy Immunol 2001; 19: 291-3.

Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med 1997; 43: 93-7.

Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS 2005; 16: 302-6.

Nissapatorn V, Lee CK, Khairul AA. Seroprevalence of toxoplasmosis among AIDS patients in Hospital Kuala Lumpur, 2001. Singapore Med J 2003; 44: 194-6.

Derouin F, Le Port C, Pueyo S, Morlat P, Letrillart B, Chêne G, Ecobichon JL, Luft B, Aubertin J, Hafner R, Vildé JL, Salamon R. Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 trial group. AIDS 1996; 10: 1521-7.

Laing RB, Flegg PJ, Brettle RP, Leen CL, Burns SM. Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. Int J STD AIDS 1996; 7: 258-64.

Oksenhendler E, Charreau I, Tournerie C, Azihary M, Carbon C, Aboulker JP. Toxoplasma gondii infection in advanced HIV infection. AIDS 1994; 8: 483-7.

Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994; 120: 932-44.

Dunlop O, Rootwelt V, Sannes M, Goplen AK, Abdelnoor M, Skaug K, Baklien K, Skar A, Melby K, Myrvang B, Bruun JN. Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis. Scand J Infect Dis 1996; 28: 71-3.

Montoya JG, Kovacs JA, Remington JS. Toxoplasma Gondii. In: Mandell GL, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone 2005; p.3170-98.

Kasper L. Infectious disease. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson LJ, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill 2005; p.1243.

How to Cite
Mohraz M, Mehrkhani F, Jam S, SeyedAlinaghi SA, Sabzvari D, Fattahi F, Jabbari H, Hajiabdolbaghi M. Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran. Acta Med Iran. 49(4):213-218.